Corcept Therapeutics Incorporated (CORT) ownership: insiders 4% · institutions 79% (13F 2026-03-31). Insider activity, 90 days: 63 sales, 0 open-market buys. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| BlackRock | 12151276.00 | $489.82M | 11.2% | 2026-03-31 |
| Vanguard | 9642162.00 | $388.68M | 8.9% | 2026-03-31 |
| Ingalls & Snyder LLC | 7608716.00 | $306.71M | 7.0% | 2026-03-31 |
| Renaissance Technologies | 5682783.00 | $229.07M | 5.3% | 2026-03-31 |
| Parallel Advisors, LLC | 3977404.00 | $160.33M | 3.7% | 2026-03-31 |
| State Street | 3200946.00 | $129.03M | 3.0% | 2026-03-31 |
| FMR (Fidelity) | 3190192.00 | $128.60M | 3.0% | 2026-03-31 |
| Geode Capital Management | 2713519.00 | $109.40M | 2.5% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-18 | |
| Sell | null | 2026-08-18 | |
| Sell | null | 2026-08-18 | |
| Sell | null | 2026-08-18 | |
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-14 | |
| Sell | null | 2026-08-14 |
Back to CORT overview · CORT earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.